Update from the Swirl (and People are Key to Success) Last weekend, I uploaded a blog post that included this graphic describing success and… October 30, 2014 Uncategorized
Innovation: Via a 5th Generation WI Life Science Company I want to share three themes that struck me from the Dohmen Life Science Services… October 25, 2014 Uncategorized
Could Pharma/Biotech Build an Amazon? Pharma/Biotech Business Model Innovation When I hear/read about business model innovation in pharma/biotech, the themes… August 26, 2014 Uncategorized
Experimenting in Academia: Indirect cost disruption? Yesterday on Twitter I asked the following question and I wanted to follow up because… July 24, 2014 Uncategorized
US Biosimilars Pathway – A Step Closer to Reality Today Sandoz announced that their Biologics License Application for filgrastim was accepted by the… July 24, 2014 Uncategorized
#wearenotwaiting is amazing This weekend I came across a blog post "CGM in the Cloud: Personal Preferences"… July 21, 2014 Uncategorized
Biotech: Outside Looking In In a post in March, I suggested that I would represent the "less glamorous… July 2, 2014 Uncategorized
ASCO 2014: People in Drug Development Reflecting on the American Society of Clinical Oncology annual meeting, I’m left thinking about… June 22, 2014 Uncategorized
(Re)Reading This Weekend (6/14/14) There were a few long reads that I'll be re-reading over the weekend, including: New… June 14, 2014 Uncategorized
Risk Distribution & Opportunity Costs in Entrepreneurship Risk Distribution In WIRED, "One Startup’s Struggle to Survive the Silicon Valley Gold Rush"… May 23, 2014 Uncategorized